Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

57205721572257235724572557265727572857295730573157325733573457355736573757385739574057415742574357445745574657475748574957505751575257535754575557565757575857595760576157625763576457655766576757685769577057715772Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged bychemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644-657.Aigner KR, Walther H, Tonn JC, Link KH, Schoch P, Schwemmle K. Isolated liver perfusion in advancedmetastases of colorectal cancers]. Onkologie 1984;7:13-21.Aigner KR, Walther H, Link KH. Isolated liver perfusion with MMC/5-FU; surgical technique, harmacokinetics,clinical results. Contr Oncol 1988;29:229-246.Ajaj W, Lauenstein TC, Pelster G, Holtmann G, Ruehm SG, Debatin JF et al. MR colonography in patients withincomplete conventional colonoscopy. Radiology 2005;234:452-9.Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S; National Surgical Adjuvant Study of ColorectalCancer. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectalexcision with selective lateral pelvic lymphadenoectomy: a multicentre randomized controlled trial. Jap J ClinOncol 2006; 36:237-44.Alberts SR, Sargent DJ, Nair S, Mahoney MR, Mooney M, Thibodeau SN, et al. Effect of oxaliplatin, fluorouracil,and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: arandomized trial. JAMA. 2012 Apr 4;307(13):1383-93. doi: 10.1001/jama.2012.385.Alcántara M, Serra-Aracil X, Falcó J, Mora L, Bombardó J, Navarro S.Prospective, controlled, randomized study of intraoperative colonic lavage versus stent placement in obstructiveleft-sided colonic cancer. World J Surg. 2011 Aug;35(8):1904-10. doi: 10.1007/s00268-011-1139-y.Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Isolated hepatic perfusion withtumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-1489.Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. A phase I-II study of isolatedhepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanomametastatic to liver. Clin Cancer Res 2000;6:3062-3070.Alexander HR Jr, Libutti SK, Pingpank JF, et al. Hyperthermic isolated hepatic perfusion using melphalan forpatients with ocular melanoma metastatic to liver. Clin Cancer Res 2003 ;9:6343-6349Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life aftertransanal endoscopic microsurgery. Br J Surg. 2011 Nov;98(11):1635-43. doi: 10.1002/bjs.7584. Epub 2011 Jun28.Allegra CJ, Yothers G, O'Connell MJ, Sharif S, Petrelli NJ, Colangelo LH, et al. Phase III trial assessingbevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol. 2011 Jan1;29(1):11-6. doi: 10.1200/JCO.2010.30.0855. Epub 2010 Oct 12.Allen DC, Fon LJ, McAleer JJ, Irwin ST. Pathology of rectal adenocarcinoma following preoperative adjuvantradiotherapy and chemotherapy. Ulster Med J 1998;68:17-21.Allen-Mersh TG, Earlam S, Fordy C, et al: Quality of life and survival with continuous hepatic-artery floxuridineinfusion for colorectal liver metastases. Lancet 1994;344:1255-1260.Allen-Mersh TG, Glover C, Fordy C, et al: Randomized trial of regional plus systemic fluorinated pyrimidinecompared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. Eur J Surg Oncol2000;26:468-473.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 141